What it is
MOTS-c is a tiny 16-amino-acid peptide your own body produces, encoded inside the mitochondria rather than the cell nucleus. It was identified in 2015 and belongs to a small family of "mitochondrial-derived peptides." It is naturally present in blood, and levels appear to decline with age.
How it works
MOTS-c is involved in metabolism and cellular energy. Skeletal muscle is its main target, where it appears to improve "metabolic flexibility" by activating AMPK, an enzyme central to how cells manage energy. Under stress it can move into the cell nucleus and influence gene expression linked to metabolism. Notably, exercise raises MOTS-c levels in human muscle and blood, which is why it is often described as an exercise-induced peptide.
What the evidence shows
This is where honesty matters. Most of the encouraging findings come from mice, not people.
- In mice, MOTS-c prevented age-related and diet-induced insulin resistance, and reduced diet-induced obesity.
- In animal and cell studies it reduced pro-inflammatory markers and improved glucose handling.
- Human studies so far are mostly observational: they measure natural MOTS-c levels and correlate them with metabolic health and exercise, rather than testing it as a treatment.
What people study it for
Research interest centres on metabolic health, insulin sensitivity, physical capacity and aging. These are areas of investigation, not proven outcomes in humans. An earlier analog reached an early human trial through a biotech company, but clinical development did not progress to an approved product.
Where it stands
MOTS-c is a genuinely interesting molecule in aging and metabolism research. But it sits firmly in the "research only" category: no approval, scant human safety data, and benefits that remain hypothetical in people. Anything sold under this name is unregulated and of unverified quality.